Development of a tool to assess outpatient opioid use
Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
This study is working on a new tool to help doctors better understand how much opioids patients are using, which will help improve pain management and support treatments for those struggling with opioid use.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mmj Labs, LLC NIH-funded |
| Lab location | 1 site (Atlanta, UNITED STATES) |
| Project ID | NIH-11240717 on NIH RePORTER |
What this research studies
This research aims to create a Clinical Outcome Assessment (COA) tool that accurately measures outpatient opioid use reported by patients. It will utilize a standardized metric, milligrams of morphine equivalents (MME), to evaluate opioid consumption through a robust survey module. The tool is designed to support clinical trials and regulatory approval processes for interventions aimed at reducing opioid use and addressing substance use disorders. By capturing comprehensive data on opioid use, the tool will enhance the understanding of pain management practices and improve patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who are prescribed opioids for pain management and are willing to report their usage accurately.
Not a fit: Patients who do not use opioids or are not involved in outpatient pain management may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for monitoring and managing opioid use, ultimately enhancing patient safety and treatment outcomes.
How similar studies have performed: Previous research has shown success in developing similar assessment tools for opioid use, indicating a promising avenue for this approach.
Where this research is happening
Atlanta, UNITED STATES
- Mmj Labs, LLC — Atlanta, United States (Active)
Researchers
- Principal investigator: Baxter, Amy Lynn — Mmj Labs, LLC
- Study coordinator: Baxter, Amy Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.